Supplementary Table S3 from SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)
Year: 2026
Type: supplementary-materials
Abstract: cfDNA fragmentation profiles in MPNST samples
Authors: AeRang Kim, Karla V. Ballman, Pamela L. Wolters, Rachel S. Heise, Jack F. Shern, R. Taylor Sundby, Liza Lindenberg, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Shirin Shahsavari, Angela C. Hirbe, Brian A. Van Tine, Christian F. Meyer, Christine A. Pratilas, Natalie B. Collins, Geraldine O’Sullivan Coyne, Alice P. Chen, Eva Dombi, Roshan L. Shrestha, Andrea M. Gross, Denise Reinke, Karen Cichowski, Brigitte C. Widemann
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7136352596